Sg Americas Securities, LLC Incyte Corp Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Incyte Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 27,444 shares of INCY stock, worth $2.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,444

Previous 67,936 59.6%

Holding current value

$2.07 Million

Previous $4.12 Million 55.95%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$57.33 - $68.61 $2.32 Million - $2.78 Million	-40,492 Reduced 59.6%	27,444 $1.81 Million
Q2 2024 Jul 12, 2024	BUY	$51.18 - $63.75 $1.22 Million - $1.52 Million	23,817 Added 53.98%	67,936 $4.12 Million
Q1 2024 May 06, 2024	BUY	$56.55 - $66.59 $357,848 - $421,381	6,328 Added 16.74%	44,119 $2.51 Million
Q4 2023 Jan 12, 2024	BUY	$52.16 - $64.19 $1.53 Million - $1.88 Million	29,315 Added 345.86%	37,791 $2.37 Million
Q3 2023 Oct 13, 2023	SELL	$57.77 - $65.93 $1.23 Million - $1.4 Million	-21,294 Reduced 71.53%	8,476 $490,000
Q2 2023 Jul 10, 2023	BUY	$60.95 - $75.51 $428,356 - $530,684	7,028 Added 30.9%	29,770 $1.85 Million
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $1.4 Million - $1.71 Million	19,894 Added 698.53%	22,742 $1.64 Million
Q4 2022 Feb 02, 2023	SELL	$67.18 - $84.11 $1.05 Million - $1.31 Million	-15,611 Reduced 84.57%	2,848 $229,000
Q3 2022 Oct 31, 2022	SELL	$66.18 - $82.86 $65,187 - $81,617	-985 Reduced 5.07%	18,459 $1.23 Million
Q2 2022 Jul 29, 2022	BUY	$66.18 - $83.18 $666,498 - $837,705	10,071 Added 107.45%	19,444 $1.48 Million
Q1 2022 Apr 29, 2022	SELL	$66.02 - $79.71 $7.35 Million - $8.87 Million	-111,284 Reduced 92.23%	9,373 $744,000
Q4 2021 Feb 07, 2022	BUY	$63.34 - $74.11 $4.67 Million - $5.47 Million	73,776 Added 157.37%	120,657 $8.86 Million
Q3 2021 Nov 01, 2021	SELL	$68.67 - $84.02 $10 Million - $12.3 Million	-146,265 Reduced 75.73%	46,881 $3.22 Million
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $11.3 Million - $12.4 Million	142,079 Added 278.22%	193,146 $16.2 Million
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $4.89 Million - $6.47 Million	-64,362 Reduced 55.76%	51,067 $4.15 Million
Q4 2020 Feb 04, 2021	BUY	$80.74 - $97.7 $5.81 Million - $7.03 Million	71,918 Added 165.29%	115,429 $10 Million
Q3 2020 Nov 09, 2020	BUY	$85.07 - $109.69 $705,145 - $909,220	8,289 Added 23.53%	43,511 $3.91 Million
Q2 2020 Jul 20, 2020	BUY	$74.18 - $108.93 $1.9 Million - $2.79 Million	25,640 Added 267.59%	35,222 $3.66 Million
Q1 2020 Apr 30, 2020	SELL	$63.18 - $85.97 $2.25 Million - $3.07 Million	-35,665 Reduced 78.82%	9,582 $702,000
Q4 2019 Jan 28, 2020	SELL	$73.04 - $95.72 $4.82 Million - $6.31 Million	-65,940 Reduced 59.31%	45,247 $3.95 Million
Q3 2019 Nov 04, 2019	BUY	$72.82 - $86.52 $6.5 Million - $7.72 Million	89,214 Added 406.02%	111,187 $8.25 Million
Q2 2019 Jul 29, 2019	BUY	$73.52 - $88.7 $1.1 Million - $1.33 Million	14,972 Added 213.86%	21,973 $1.87 Million
Q1 2019 Apr 29, 2019	SELL	$63.56 - $88.17 $298,922 - $414,663	-4,703 Reduced 40.18%	7,001 $602,000
Q4 2018 Feb 01, 2019	SELL	$58.5 - $69.94 $3.9 Million - $4.66 Million	-66,688 Reduced 85.07%	11,704 $744,000
Q3 2018 Nov 06, 2018	SELL	$61.75 - $74.23 $1.18 Million - $1.42 Million	-19,115 Reduced 19.6%	78,392 $5.42 Million
Q2 2018 Aug 07, 2018	BUY	$60.85 - $83.98 $3.45 Million - $4.76 Million	56,699 Added 138.94%	97,507 $6.53 Million
Q1 2018 May 03, 2018	SELL	$83.06 - $100.98 $3.18 Million - $3.87 Million	-38,284 Reduced 48.4%	40,808 $3.4 Million
Q4 2017 Jan 24, 2018	SELL	$93.56 - $116.6 $420,832 - $524,466	-4,498 Reduced 5.38%	79,092 $7.49 Million
Q3 2017 Nov 07, 2017	BUY	$109.15 - $138.27 $9.12 Million - $11.6 Million	83,590	83,590 $9.76 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Incyte Corp Transaction History